Biofrontera (BFRIW) Common Equity (2020 - 2025)
Historic Common Equity for Biofrontera (BFRIW) over the last 6 years, with Q3 2025 value amounting to -$2.6 million.
- Biofrontera's Common Equity fell 14667.27% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 14667.27%. This contributed to the annual value of $4.4 million for FY2024, which is 751.1% down from last year.
- Latest data reveals that Biofrontera reported Common Equity of -$2.6 million as of Q3 2025, which was down 14667.27% from -$4.7 million recorded in Q2 2025.
- In the past 5 years, Biofrontera's Common Equity registered a high of $23.9 million during Q4 2022, and its lowest value of -$17.4 million during Q3 2021.
- Its 5-year average for Common Equity is $6.6 million, with a median of $5.2 million in 2023.
- In the last 5 years, Biofrontera's Common Equity surged by 43275.53% in 2024 and then tumbled by 14667.27% in 2025.
- Biofrontera's Common Equity (Quarter) stood at $11.3 million in 2021, then surged by 110.6% to $23.9 million in 2022, then crashed by 79.93% to $4.8 million in 2023, then dropped by 7.51% to $4.4 million in 2024, then tumbled by 158.22% to -$2.6 million in 2025.
- Its Common Equity stands at -$2.6 million for Q3 2025, versus -$4.7 million for Q2 2025 and $500000.0 for Q1 2025.